A Controlled Cross-over Study of Trimipramine and Amylobarbitone
- 1 June 1967
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 113 (499) , 667-670
- https://doi.org/10.1192/bjp.113.499.667
Abstract
Chemically, trimipramine has an imino-benzyl nucleus and a side-chain resembling that of methotrimeprazine [5-(3-dimethyl-amino-2-methyl-propyl)-10, 11-dihydrodibenz (b, f,) azepine]. In “double blind” controlled comparisons of trimipramine and imipramine, Salzmann (1965) in 27 hospitalized depressed patients who did not require ECT, found the two drugs not significantly different in effect. Blumenthal and Seppala (1965) obtained similar results. Burns (1965), however, in 44 patients suffering from psychotic depression, found trimipramine to be significantly superior at the 5 per cent. level to imipramine in ratings of recovery from depression, anxiety and insomnia. No difference was found in the latency interval between the drugs.Keywords
This publication has 6 references indexed in Scilit:
- Preliminary Evaluation of a New Anti-Depressant, Trimipramine, by a Sequential MethodThe British Journal of Psychiatry, 1965
- Dubbel-blindundersökning med Surmontil och TofranilNordisk Psykiatrisk Tidsskrift, 1965
- A Validation Study of NealbarbitoneThe British Journal of Psychiatry, 1964
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- “Mobility” in chronic schizophrenia with special regard to psychosurgeryPsychiatric Quarterly, 1956
- RESERPINE IN THE TREATMENT OF ANXIOUS AND DEPRESSED PATIENTSThe Lancet, 1955